Finance ❯ Investments

Mergers and Acquisitions

Corporate Strategy Market Trends Public Companies Pharmaceutical Industry Airline Industry Asset Sale Takeover Bids Novartis Deal Structure Morgan Stanley Special Purpose Acquisition Companies International Investments TikTok Deal OnlyFans Sale Unicredit and Commerzbank Reverse Listings Fintech Corporate Finance Shareholder Value Electronic Arts WarnerMedia Acquisition Market Share Biopharma Valuation Google Stock Transactions Biotech Sector Crypto Companies Valuation Market Opportunities Stake Purchases Corporate Valuation Institutional Investors Venture Capital

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

The purchase brings a first-in-class MLLT1/3 protein degrader into Amgen’s oncology research.

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Exodus to Acquire Uruguay’s Grateful to Expand Stablecoin Payments for Latin American Merchants

Longleaf Partners’ Q3 Letter: Fund Lags Benchmarks as Buybacks Drive Value Plan

NYDIG Urges Bitcoin Treasury Firms to Scrap mNAV After Strive–Semler Deal

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy